PHENITAB® 18, PHENITAB® 27, PHENITAB® 36, PHENITAB® 54


18 mg, 27 mg, 36 mg, 54 mg extended release tablets (30)
scheduling status
S6
registration number
56/1.2/0587, 56/1.2/0588, 56/1.2/0589, 56/1.2/0590
What PHENITAB® 18, PHENITAB® 27, PHENITAB® 36, PHENITAB® 54 contains
PHENITAB 18®: Each extended release tablet contains 18 mg methylphenidate hydrochloride. PHENITAB 27®: Each extended release tablet contains 27 mg methylphenidate hydrochloride. PHENITAB 36®: Each extended release tablet contains 36 mg methylphenidate hydrochloride. PHENITAB 54®: Each extended release tablet contains 54 mg methylphenidate hydrochloride.
other ingredients
Contains sugar (lactose monohydrate, 40 mg). Tablet core: Colloidal anhydrous silica, Hypromellose Iron oxide black, Macrogol, Magnesium Stearate, Sodium Chloride, Succinic Acid. Tablet coating: Cellulose Acetate, Macrogol, Opadry Clear (consisting of hypromellose and macrogol). Colour coating: PHENITAB 18®: Opadry II Yellow (consisting of lactose monohydrate, hypromellose, titanium dioxide, triacetin, yellow iron oxide and red iron oxide). PHENITAB 27®: Opadry II Grey (consisting of lactose monohydrate, hypromellose, titanium dioxide, triacetin, black iron oxide and red iron oxide). PHENITAB 36®: Opadry II White (consisting of lactose monohydrate, hypromellose, titanium dioxide, triacetin) PHENITAB 54®: Opadry II Pink (consisting of lactose monohydrate, hypromellose, titanium dioxide, triacetin and red iron oxide).
Therapeutic classification
N06BA04: Centrally acting sympathomimetics. A 1.2 Psychoanaleptics (antidepressants).
© 2026 SAHPRA. ALL RIGHTS RESERVED